ADCBio
www.sterlingpharmasolutions.comADC Biotechnology Ltd, now Sterling Pharma Solutions' Deeside facility, was founded in 2010 to develop and commercialise next generation conjugation technologies to the Antibody Drug Conjugate market. Find out more at: https://www.sterlingpharmasolutions.com/adcs/
Read more
ADC Biotechnology Ltd, now Sterling Pharma Solutions' Deeside facility, was founded in 2010 to develop and commercialise next generation conjugation technologies to the Antibody Drug Conjugate market. Find out more at: https://www.sterlingpharmasolutions.com/adcs/
Read more
Country
City (Headquarters)
Deeside
Industry
Employees
11-50
Founded
2010
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Head of Technical Services
Email ****** @****.comPhone (***) ****-****Head of Quality Control
Email ****** @****.comPhone (***) ****-****Team Leader
Email ****** @****.comPhone (***) ****-****Quality Assurance Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(33)
Reach decision makers at ADCBio
Free credits every month!
ADCBio FAQ
Deeside, United Kingdom
Biotechnology Research
